Bluejay Diagnostics (BJDX) Income from Continuing Operations (2020 - 2026)

Bluejay Diagnostics (BJDX) has 7 years of Income from Continuing Operations data on file, last reported at 2019972.0 in Q1 2026.

• For the quarter ending Q1 2026, Income from Continuing Operations fell 5.79% year-over-year to 2019972.0; the trailing twelve-month figure through Mar 2026 stood at 7021087.0 (up 12.52% YoY), and the FY2025 full-year result was 18945019.0, down 11.06% from the prior year.
• Income from Continuing Operations fell to 2019972.0 in Q1 2026, from 1430391.0 in the prior quarter.
• In the past five years, Income from Continuing Operations ranged from a high of 1430391.0 in Q4 2025 to a low of 3003688.0 in Q2 2023.
• A 5-year average of 2212792.06 and a median of 2125973.0 in 2022 frame the typical range for Income from Continuing Operations.
• Across the five-year window, Income from Continuing Operations plunged 791.77% in 2022 and surged 36.48% in 2024, its largest moves.
• Tracing BJDX's Income from Continuing Operations over 5 years: stood at 2490229.0 in 2022, then rose by 2.39% to 2430672.0 in 2023, then climbed by 12.77% to 2120167.0 in 2024, then soared by 32.53% to 1430391.0 in 2025, then sank by 41.22% to 2019972.0 in 2026.
• Business Quant data shows BJDX's Income from Continuing Operations at 2019972.0 in Q1 2026, 1430391.0 in Q4 2025, and 1604994.0 in Q3 2025.